
Sarah Reeves
@slreevesum
Sarah Reeves, PhD, MPH, Assistant Professor at University of Michigan, Pediatrics and Epidemiology @UMchear @umichsph
ID: 3166257923
http://chear.org 14-04-2015 16:51:12
319 Tweet
281 Followers
663 Following


The Susan B. Meister Child Health Evaluation and Research Center (CHEAR) at University of Michigan invites applications for a full-time faculty position. Learn more & apply here: ow.ly/9jzO50LsOxQ


The Susan B. Meister Child Health Evaluation and Research Center (CHEAR) at University of Michigan invites applications for a full-time faculty position. Learn more & apply here: ow.ly/9jzO50LsOxQ


A new IHPI brief highlights a partnership between a U-M team led by Sarah Reeves & Michigan HHS Dept focused on identifying adults with #sicklecelldisease who are eligible to receive coverage for care due to a recent expansion of a state health services program. ihpi.umich.edu/sicklecell





Hydroxyurea remains underused among certain children with sickle cell anemia, according to research by Sarah Reeves, despite the agent having been previously established as the primary disease-modifying therapy for individuals with the disease. bit.ly/3Lbc91z


🚨 There are just few weeks left to apply to join the 2024-26 cohort of National CSP Nat’l Clinician Scholars Program at U-M IHPI! 🚨 MDs, DOs, & RNs with a doctoral degree who are interested in conducting research to inform #healthpolicy & practice should submit applications by 7/17: nationalcsp.org/apply



HAPPENING TODAY! CHEAR Faculty Sarah Reeves, Research Staff Hannah Peng, MPH, and Missy Plegue, MA, Fellow Melinda Rushing, PhD, and Student Research Associate Jennylee Swallow will be presenting at the SCDC Summit. View the agenda & register for free: bit.ly/3OGsA9m


We are now accepting applications for the HSR T32 training program! Please share with those who may be interested. Questions and application materials can be sent to [email protected].



📰 Detroit Free Press: Only 1 Michigan hospital to initially offer new sickle cell gene editing treatment. @UMichSPH prof @MelissaSCreary is concerned that affordability and access hurdles will deepen health inequities, particularly for Black & brown patients myumi.ch/bynEj


